Michael L. Jones, Executive Director, Finance - PAO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 2,300 shares at $17.20 ($40K) on 2022-03-01, disclosed to the SEC on 2022-03-03.
Open-market sale of $40k BCRX by Executive Director, Finance - PAO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |